Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial

Autor: Michael Maeng, Christian Bradaric, Michael Joner, Evgeny Kretov, Karl-Ludwig Laugwitz, Salvatore Cassese, Mira Heugl, Javier Cuesta, Robert A. Byrne, Fernando Alfonso, Evald Høj Christiansen, Constantin Kuna, Jens Wiebe, Adnan Kastrati, Heribert Schunkert, Tareq Ibrahim, Fernando Rivero

Publikováno v: EuroIntervention
Wiebe, J, Byrne, R A, Alfonso, F, Maeng, M, Bradaric, C, Kretov, E, Cuesta, J, Kuna, C, Ibrahim, T, Rivero, F, Heugl, M, Christiansen, E H, Joner, M, Schunkert, H, Laugwitz, K-L, Kastrati, A & Cassese, S 2022, ' Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction : two-year results of the randomised ISAR-Absorb MI trial ', EuroIntervention, vol. 17, no. 16, pp. 1348-1351 . https://doi.org/10.4244/EIJ-D-21-00653

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db8f470e738c181941400fbff33bd93f
https://doi.org/10.4244/eij-d-21-00653